Marijuana Stocks CGRW
Search

cannavest corp - search results

If you're not happy with the results, please do another search

0 179

CannaVest Corp. and Project CBD Issue Joint Statement Announcing Cooperative Efforts to Benefit Industry

LAS VEGAS, Dec. 8, 2014 /PRNewswire/ — CannaVest Corp. (OTCBB:CANV), a leading manufacturer and distributor of hemp and Cannabidiol (CBD) based products, announces that it is begun cooperative efforts with Project CBD and its Director, Martin A. Lee, to ensure the cannabis/hemp industry and the consuming public is provided with accurate and meaningful information concerning CannaVest Corp.’s CBD offerings. Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the cannabis plant.

“We are pleased to be working with Project CBD and Martin Lee to ensure consumers and the marketplace are provided reliable data concerning our products,” said Michael Mona, Jr., President and Chief Executive Officer of CannaVest Corp.  “We will commence our joint efforts immediately, and look forward to reporting the results of our cooperative activities to our stockholders and the general public,” continued Mr. Mona.

The full text of the Joint Statement is reprinted below:

JOINT STATEMENT

CannaVest Corporation (“CannaVest”) and Project CBD, a non-profit organization, along with its Director, Martin A. Lee, jointly issue this statement:

In a special report on the hemp oil industry published on October 14, 2014 titled “Hemp Oil Hustlers”, Project CBD reported that a consumer product, which is labeled as containing hemp oil and which was produced by CannaVest and then sold in 2013 to a distributor in 2013, tested positive for hexane and other solvent residues, none of which were listed as or intended to be ingredients in this product.

Since the October 14 publication, Project CBD corrected its report in some respects and posted those revisions on its web site. In an effort to provide accurate information to consumers and the public about the report and about CannaVest’s products, the parties have been in frequent communication with one another.  As a result, both parties now agree that it is important to emphasize to the marketplace each of the following:

  • The Project CBD report did not conclude that CannaVest was responsible for the presence of solvent residue in the product samples.
  • The Project CBD report did not conclude that other products containing hemp oil manufactured by CannaVest contain residual solvents.
  • The Project CBD report did not conclude that the solvent residues reported by Project CBD were responsible for consumer complaints of adverse health events after consumption of the CannaVest product that was tested by Phytatech and Flora Research Laboratories.

CannaVest acknowledges that at the time of its October 24, 2014 report to its stockholders, it did not have in its possession important facts about the scope of the testing undertaken by Flora Research Laboratories, its testing procedures and equipment used when it tested the samples it received from third parties (not CannaVest) for Project CBD. Flora Research Laboratories’ goal was not to perform quality control testing on the samples nor to determine compliance with any established residue limits, but rather to conduct a phytoforensic examination of the samples to assist PhytaTech lab in investigating unidentified peaks, and completing its analysis. Now with a further understanding of the testing procedures, CannaVest withdraws its comments about the lack of quality of the analytical testing conducted.

Significantly, Project CBD and CannaVest have agreed to jointly test samples of CannaVest’s currently produced  hemp oil product  in order to determine the absence or presence of heavy metals and industrial solvents in that product.  The parties are in the process of agreeing upon the selection and number of samples to be tested, the parameters of the testing, the lab that will conduct the testing, and the timing of the testing, which the parties intend to undertake shortly. The parties will make public the results of that testing.

Finally, both CannaVest and Project CBD acknowledge that this cooperative effort may be the beginning of a more extensive working relationship aimed at providing accurate and meaningful information to the cannabis/hemp industry and to the consuming public.

About CannaVest Corp.
CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visitingwww.cannavest.com.

CannaVest Corp.’s subsidiaries include: US Hemp Oil, LLC (www.USHempOil.com) that provides seed procurement, cultivation, processing, and production consultation, and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US; and CannaVest Laboratories, LLC (www.CannaVestLabs.com), that facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil, and is the developer and manufacturer of CannaVest’s own award winning CBD Simple.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE
CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Logo – http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cannavest-corp-and-project-cbd-issue-joint-statement-announcing-cooperative-efforts-to-benefit-industry-300006041.html

0 396

CannaVest Corp. Garners Industry Record Sixth Cannabis Cup Award for Highest Cannabidiol (CBD) Concentrate

LAS VEGAS, Dec. 2, 2014 /PRNewswire/ — CannaVest Corp. (CANV), a leading manufacturer and distributor of hemp and Cannabidiol (CBD) based products was awarded first place honors once again for the Highest CBD Concentrate of its CBD Simple hemp Cannabidiol (CBD) oil at the 2014 High Times Cannabis Cup in Amsterdam, The Netherlands on Thursday November 27, 2014. This is the company’s industry record sixth first place High Times Cannabis Cup win in the CBD concentrate category. The company’s High Times Cannabis Cup awards include first place in Seattle and Amsterdam in 2013, as well as first place awards in Los Angeles, Michigan, and Seattle in 2014. In addition, CannaVest Corp. received the first place win at the 2013 Michigan Green Cup in the CBD concentrate category.

CannaVest Corp - The World's Leading Industrial Hemp Supplier.

“We at CannaVest Corp. take great pride in our Cup wins, which demonstrates our commitment to producing the highest quality end-consumer hemp and CBD products in the marketplace,” stated President and CEO, Michael J. Mona, Jr. “The market is taking notice that our CBD Simple™ provides the most reliable, highest quality CBD concentrate available, as evidenced by our continued traction and rapid customer growth,” continued Mr. Mona. “Our product quality, our seasoned and credentialed management team and our transparency in the marketplace has put CannaVest Corp. at the top of CBD providers,” Mr. Mona stated.

Cannabidiol (CBD) is a non-psychoactive nutraceutical product isolated from industrial hemp for use in cosmetics and supplements, and has been recognized by the National Institutes of Healthfor its pluripotent benefits on human health.

PlusCBD™ Oil is the consumer grade version of CBD Simple, developed exclusively byCannaVest Laboratories, a division of CannaVest Corp. in San Diego, California.

CannaVest Corp. manufactures and distributes PlusCBD™ Oil as a raw bulk product, and as well as its own lines of end-consumer products containing PlusCBD™ Oil. The Cibaderm™ body care line includes Shampoo, Conditioner, and Body Wash, and Hand and Body Lotions. TheCibdex™ line delivers CBD in drop, spray and capsule form. The Company products are available on its PlusCBD™ Products website.

About CannaVest Corp.

CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visitingwww.CannaVest.com.

CannaVest Corp.’s subsidiaries include: US Hemp Oil, LLC (www.USHempOil.com) that provides seed procurement, cultivation, processing, and production consultation, and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US; and CannaVest Laboratories, LLC (www.CannaVestLabs.com), that facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil, and is the developer and manufacturer of CannaVest’s own award winning CBD Simple.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE

CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Logo – http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cannavest-corp-garners-industry-record-sixth-cannabis-cup-award-for-highest-cannabidiol-cbd-concentrate-300003258.html

0 354

CannaVest Corp. Reports Third Quarter 2014 Financial Results

LAS VEGAS, Nov. 14, 2014 /PRNewswire/ — CannaVest Corp. (“CannaVest” or the “Company”) is reporting financial results for the quarter ended September 30, 2014.

During the third quarter we terminated our Non-Exclusive License and Distribution Agreement (the “HempMeds Agreement”) with HempMeds PX, LLC (“HempMeds”).  The HempMeds Agreement granted HempMeds a non-exclusive, worldwide license and right to promote, market, sell, distribute and service the Company’s products and an exclusive right to online sales.  The HempMeds Agreement termination resulted in a significant revenue loss for the Company but provided an opportunity for CannaVest to better control its sales channels, brand awareness and future profitability without having to rely on a single customer relationship.  The termination also allowed CannaVest to pursue revenue from online sales.

“Our worldwide commitment to expanding the science, awareness and benefit of our PlusCBD™ brand of cannabidiol oil and products is gaining traction,” said Mr. Mona.  “The termination of the HempMeds Agreement required that we immediately expand our sales and marketing capability to better control the growth trajectory of CannaVest.  We have expanded our sales force, commenced e-commerce operations and have made strategic marketing investments.  Since the termination, we have made great progress. In less than one month we have transitioned from a single customer to literally hundreds of customers.”  Mr. Mona continued, “Our goal is to make our product portfolio available to the mainstream consumer market and we continue to make good progress in that direction.”

Third Quarter 2014 Operating Results
The Company’s net loss for the third quarter of 2014 was $482,129, or $0.01 per share (basic and diluted), compared to a net loss of $810,761, or $0.08 per share (basic and diluted) for the same period in 2013.

Selling, general and administrative expenses for the third quarter of 2014 were $1,350,639 compared to $653,872 for the same period in 2013.  The increase was related to increased personnel in all functional areas, further investment in technology infrastructure and increased legal and marketing expense.

Research and development costs for the third quarter of 2014 were $262,065 compared to $137,496 for the same period in 2013.  This includes the cost of process development, rental of laboratory space, personnel costs, laboratory supplies and product development and testing.

Balance Sheet Highlights
As of September 30, 2014, the Company had cash of approximately $4.7 million.  Stockholders equity amounted to approximately $21.9 as of September 30, 2014.

For further discussion of the Company’s financial results for the period ended September 30, 2014, please refer to the Company’s consolidated financial statements and related Management Discussion and Analysis, which can be found at www.cannavest.com or EDGAR atwww.sec.gov/edgar/searchedgar/webusers.htm in the Company’s Quarterly Report on Form 10-Q as filed with the U.S. Securities and Exchange Commission on November 11, 2014.

About CannaVest Corp.
CannaVest Corp. (CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visitingwww.CannaVest.com.

CannaVest Corp.’s subsidiaries include: US Hemp Oil (www.USHempOil.com) that provides seed procurement, cultivation, processing, and production consultation, and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US;  and CannaVest Laboratories (www.CannaVestLabs.com), that facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil, and is the developer and manufacturer of CannaVest’s own award winning CBD Simple.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE
CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Logo – http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

0 354

CannaVEST Corp. CEO Releases Letter to Stockholders and Customers Regarding Report Issued by Project CBD

LAS VEGAS, Oct. 24, 2014 /CNW/ — CannaVEST Corp. (OTC:CANV), a leading manufacturer and distributor of hemp and cannabidiol (CBD) based products, released a letter from Michael Mona, Jr., Chief Executive Officer, to stockholders and customers regarding a recent report issued by Project CBD:

Dear Stockholders and Customers,

First, thank you for your continued support of and belief in our company. As you may be aware, on October 14, 2014, Project CBD, an organization claiming to be an educational service on the medical utility of the cannabis plant, issued a “special report” titled Hemp Oil Hustlers. In the report, Project CBD makes numerous allegations against individuals and companies in the CBD industry who are not involved with or related to our company. However, of particular concern are the allegations and statements of purported fact concerning the quality and safety of our products.

We owe it to our stockholders and customers to respond to such allegations. The claims disparaging our products are based on scientific inconsistencies, critical flaws in the methodology used to perform tests and false data. Our industry as a whole is subject to numerous attacks, and typically we do not merit such attacks with a response. In this instance, where the quality and safety of our products is attacked, we owe it to our customers and stockholders to respond.

Our methods for processing our hemp oil are expertly controlled from seed to sale. We have invested substantial effort and capital in establishing a world-class research laboratory and processing facility to ensure that our processes for purifying and processing cannabidiol (CBD) exceed all applicable standards. Our lab has achieved purification in excess of 97% on natural (non-synthetic) hemp-based CBD, and our processes and the efforts of our scientific team should be applauded and not disparaged.

With regard to the specific allegations made by Project CBD:

  1. Residual Solvents and Heavy Metals – We do not use solvents in our extraction process.  However, the Project CBD report claims that two of the five samples of RSHO tested positive for residual solvents. The Report states “these are all class one solvents, the most dangerous and toxic class of solvents.” First, the solvents identified by Project CBD in the report (hexane, pentane, butane and ethyl acetate) are, in fact, not Class I solvents as defined by the United States Pharmacopia (USP). The identified solvents are either Class II or Class III solvents, and the USP has set acceptable exposure limits for Class II and Class III compounds.

    With respect to heavy metals, our products have, without exception, tested below the practical quantitation limits for the industry standard ICP-MS method as set forth in Steep Hill’s monograph titled, “Testing Cannabis for Contaminants.” Quite simply our products fall safely in line with the applicable standards, and the Project CBD report is uninformed and just plain wrong.

  2. Testing Methods – In addition, the conclusions reported as fact by Project CBD are based on suspect methods. First, Project CBD concedes its sample batches had no chain of custody controls. The samples (allegedly) tested by Project CBD were obtained from third parties. Also, the laboratory used by Project CBD (Flora Research Laboratories) had critical flaws in its methodology – flaws that would prevent the release of data by any reputable, unbiased lab. Specifically, the analysis performed by Flora Research confirmed there were major residue impurities on their injection needle that would lead to carryover between samples. Flora Research also employed shoddy procedures relating to the wash out of nonpolar hemp oil from their needle, which would not dissolve the hemp oil matrix.

    Based on the testing methods utilized by Flora Research, and what is likely a bias based on its relationships with other CBD suppliers, Project CBD’s data should be disregarded. Although written in a manner to suggest it is objective journalism, the Report should be read for what it is – an effort to discredit our company for the benefit of its competitors.

We have asked the Director of Project CBD, Martin A. Lee, to work with us to vet his conclusions and statements in the interest of ensuring the public has accurate and reliable data concerning our products. Mr. Lee has accepted our invitation and we plan to educate Mr. Lee on our processing methods and protocols.  We also will work with Project CBD to provide reliable and accurate test results.  Ultimately, we are confident Project CBD will agree its report is fatally flawed as it relates to its conclusions about our products.  We look forward to working with Project CBD, because we are confident our processes and end products are the highest quality in the world.

My intention with this letter is to ensure our stockholders and our customers have accurate data concerning the viability and safety of our products. We stand behind our processes and procedures, and we are proud of what we have accomplished to date. We continue to work hard to become world’s largest – and most respected – developer of CBD-based products.

Michael Mona, Jr.
CEO
CannaVEST Corp.

About CannaVEST Corp.

CannaVEST Corp. (OTCBB:CANV), based in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CannaVEST resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visiting www.cannavest.com.
CannaVEST Corp.’s subsidiaries include CannaVest Laboratories, LLC (www.CannaVestLabs.com), which facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil, and is the developer and manufacturer of CannaVEST’s own award winning CBD Simple, and US Hemp Oil, LLC (www.USHempOil.com), which provides seed procurement, cultivation, processing, and production consultation, and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US.US Hemp Oil plans to build seed-processing mills and bring hemp-based products to market.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

CONTACT: Investor Relations, 866-290-2157

0 250

CannaVest Corp. introduces Wide Range of Formulation-Ready CBD products at SupplySide West Trade Show

LAS VEGAS, Oct. 2, 2014 /PRNewswire/ — CannaVest Corp. (OTCBB: CANV), a leading supplier of cannabidiol (CBD) based compounds and products, will be showcasing their range of PlusCBD Oil™ and retail products in Booth #22023 at the SupplySide West trade show on October 6-10, 2014, in Las Vegas, Nevada. In its fifteenth year, the show is billed as the world’s largest expo gathering for ingredient suppliers and finished product manufacturers. This year, the expo will be showcasing CannaVest’s wide range of formulation-ready CBD products, and the Company will be participating in the CBD and the Hemp Revolution seminar, from 8:30 to 11:30 a.m. on October 10th to discuss the biochemical, scientific, medical and consumer applications of CBD.

Stuart Tomc, Vice President of Human Nutrition, notes that nutraceutical companies and food formulators are looking for reliable sources of plant-based compounds that are natural, organic, and non-GMO.
Michael Mona, Jr., President and CEO, states that “CannaVest Corp. is the industry leading supplier of CBD and is also innovating new products to meet consumer demand, including our novel water soluble CBD concentrate, formulation-ready CBD powder for both nutraceutical and food products, and the Company award winning range of CBD rich hemp oil that is tested and certified from seed to shelf.”

About CannaVest Corp.

CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available from OTCMarkets.com or by visiting http://www.CannaVest.com.

CannaVest Corp.’s subsidiaries include: US Hemp Oil, LLC (“US Hemp Oil”) (http://www.USHempOil.com), CannaVest Laboratories, LLC (“CannaVest Laboratories”) (http://www.CannaVestLabs.com) and Plus CBD, LLC (formerly, Global Hemp Source, LLC) (“Plus CBD”). US Hemp Oil provides farming, procurement, processing, marketing and distribution services of bulk wholesale hemp seed. In addition, US Hemp Oil is involved with industry advocacy, creating greater public awareness and media exposure for the nutritional profile of hemp seeds and the environmental benefits of growing industrial hemp. CannaVest Laboratories provides processing technology and product development of hemp-based nutraceutical products. Plus CBD Oil is the operating entity for Company sales and expense of CBD oil and end consumer products.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE

CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Logo – http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

SOURCE CannaVest Corp.

Copyright (C) 2014 PR Newswire. All rights reserved

    0 0

    Following is a list of cannabis stocks who have made our radar at Marijuana Stocks at one time or another. This is not a comprehensive list and should be used only as a starting point for your own research. The following are not paid listings and are not recommendations to buy or sell any Marijuana Stocks listed here.

    Companies within the Cannabis Industry change direction and business models quickly. Some never develop beyond a plan or forward looking statements in a couple press releases. NOTE: Some marijuana companies shown in our delayed quotes may not be listed on this page.

    nodivingNovice investors or those unfamiliar with Penny Stocks should read our welcome page. We suggest your first due diligence is to contact any company (and/or their Investor Relations) to determine their current direction and activities in the Marijuana Sector. Please understand; there will be companies who do nothing more in this industry than attach themselves to it when it’s hot — via press releases — just like many do with gas, gold, oil, mining, health, and any other sectors garnering media attention at the time. If you don’t understand why they do this, we encourage you to focus your efforts on learning before investing any money.

    If your company is on this list and should be removed, please contact us. If you’re publicly traded cannabis company is not on the list and should be, contact us with details for consideration.

    NOTE: Charts are 1-day, and are not real-time


    CannaVEST Corp. (CANV )

    (Formerly FCLS)
    2688 South Rainbow Avenue
    Suite B
    Las Vegas, NV 89146
    Phone: 866-290-2157

    Altitude Organic Corporation (ERBB )

    (formerly Amergence Group, Inc. – AMNG)
    14220 N. Northsight Blvd.
    Suite 139
    Scottsdale, AZ 85260
    Phone: 480-443-1600
    Fax: 424-288-5523

    BG Medical Technologies, Inc. (RIGH )

    Formerly Rightsmile
    1702 A Street
    Sparks, NV 89431
    Phone: 855-723-3283

    Cannabis Science, Inc. (CBIS )

    548 Market Street
    Suite 16645
    San Francisco, CA 94104
    Company: Website | Email | Map
    Phone: 888-889-0888
    Fax: 866-943-5085

    Creative Edge Nutrition, Inc. (FITXD )

    29235 STEPHENSON HIGHWAY
    STE 206
    Madison Heights, MI 48071
    Phone: 407-362-7138

    ENDEXX Corp. (EDXC )

    PO Box 4317
    Phone: 480-595-6900
    Fax: 85331

    GreenGro Technologies, Inc. (GRNH )

    8251 La Palma Ave.
    Buena Park, CA 90260
    Phone: 949-891-8933
    Fax: 949-209-1861

    Growblox Sciences, Inc. (GBLX) (GBLX )

    GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pioneering the medical marijuana industry by combining Agriculture with Biotechnology. The Company’s cutting-edge cultivation technology allows for exact and consistent growth of the highest medical-grade cannabis for direct dispensary sale of the cannabis plant, marijuana. Moreover, their cannabinoid research and extraction process adds a biotech element to manufacture and acquire strains of medical cannabis and cannabis oils to treat patients with specific medical conditions.
    7251 W. LAKE MEAD BLVD
    STE 300
    Las Vegas, Nevada 89128
    Phone: 1-888-895-3594

    Growlife, Inc. (PHOT )

    30C Mill St.
    Healdsburg, CA 95448
    Phone: 800-977-5255
    Properties: Stealth Grow LED, SG Sensors, Greners.com, Cannabis.org, Urban Garden Supplies, Phototron, GrowLife Productions

    Hemp, Inc. (HEMP )

    8174 S. Las Vegas Blvd.
    #109367
    Las Vegas, NV 89123
    Phone: 877-221-8351

    Medbox, Inc. (MDBX )

    8439 W. Sunset Blvd.
    Suite 101
    West Hollywood, CA 90069
    Phone: 800-762-1452
    http://www.vaporfection.com http://www.thedispensingsolution.com

    Medical Marijuana, Inc. (MJNA )

    27472 Portola Pkwy
    #205-326
    Foothill Ranch, CA 92610
    Phone: 888-682-6562

    MediSwipe, Inc (MWIP )

    (formerly Cannabis Medical Solutions – CMSI)
    4400 PGA Blvd
    Suite 900
    Palm Beach Gardens, FL 33410
    Phone: 305-396-9097

    Nuvilex, Inc. (NVLX )

    12510 Prosperity Drive
    Suite #310
    Silver Spring, MD 20904
    Phone: 480-348-8050

    Rapid Fire Marketing, Inc. (RFMK )

    1802 N. Carson St.
    Carson CityNV, NV 89701
    Phone: 775-887-0670
    Fax: 775-887-0738

    Terra Tech Corp. (TRTC )

    18101 Von Karman
    Third Floor
    Irvine, CA 92612
    Phone: 855-447-6967

    Vaporin, Inc. (VAPOD )

    Vaporin, Inc. develops, markets, and sells electronic cigarettes and related products. It also offers Vaporin Pens, e-liquids, kits and accessories, and replacement parts, including batteries, refill cartridges, and cartomizers that contain the liquid solution, atomizers, tanks, and e-liquids. The company sells its products directly through a network of stores in the United States, as well as online. It ships its products to customers in the United States and internationally. Vaporin, Inc. is headquartered in Miami, Florida.
    4400 BISCAYNE BOULEVARD
    Miami, Florida 33137
    Phone: +1-888-734-4361
    Fax: +1-800-253-5177

    X-Change Corporation (The) (XCHC )

    12655 North Central Expressway
    Suite 1000
    Dallas, TX 75243
    Phone: 719-418-2286

     

    3 1216

    Written by: Anthony DelCioppo

    Imagine reading your grammar school text books on hemp paper?  Or how about driving a car built with hemp that is also powered by hemp? Or what about having a couple of the most revered documents in American history written on hemp paper in the Declaration of Independence and the Constitution?  Or better yet, brace yourself; what about paying your taxes with hemp?

    Believe it or not from 1631 until the early 1800’s it was completely legal to pay your taxes with hemp (I should also mention it was also legal to pay your taxes with tobacco, cotton, and even alcohol). In fact, in 17th century America, farmers in Virginia, Massachusetts, and Connecticut were actually ordered by law to grow Indian hemp, and by the early 18th century a farmer could be prosecuted if they weren’t growing hemp on their land. Here we sit in the 21st century fighting the good fight to legalize marijuana from state to state with hopes to one day see marijuana declassified as a Schedule I drug federally; but what about its bud-less sister-plant, hemp?

    Founding Fathers and War Hemp

    Many believe that the Constitution, the Declaration of Independence, and even the Bill of Rights were written on hemp paper. Historians are quick to point out that all three are written on Parchment (which is treated animal skin), but it is however generally accepted that the drafts for these documents were likely written on hemp paper. We know that Thomas Jefferson and George Washington grew hemp and we know that hemp paper can last at least 1500 years. Hemp fiber paper resists decomposition, doesn’t yellow with age, and can be recycled much more than wood based paper.

    Farmers around the world have been growing hemp legally for thousands of years. So what happened with America? In the late 1930’s Congress passed the Marijuana Tax Act which effectively made hemp cultivation impossible with the tax and licensing regulations. A few years later the attack on Pearl Harbor halted the importation of Manila hemp from the Philippians which lead the government to form a private company called War Hemp Industries to subsidize hemp cultivation. The government grew over a million acres of hemp in the Midwest until the war was over and all of the hemp processing plants were shut down.

    But why hemp?

    The list of uses for hemp seems endless: fuel, oil, paper, food, clothing, medicine, plastic, skin care…Hemp was mankind’s leading crop for 8,000 years and is due for a comeback. However, America is the only industrialized nation in the world that doesn’t seem to recognize the value of industrial hemp or allow its production. Here are a few countries that ‘get it’: Australia, Canada, China (the largest exporter of hemp textiles), France, Germany, Great Britain, India, Italy, Japan, Spain, Korea — you get the picture.
    hempcan
    That said the country does seem to be getting much more progressive as more research is done on the benefits of marijuana and the uses of industrial hemp and legislation reflects that. Within the last two years we’ve seen Colorado, Washington, Oregon, Alaska, and Washington D.C. legalize marijuana for recreational use. As far as industrial hemp is concerned, 22 states have introduced legislation, including VT, HI, ND, MT, MN, IL, VA, NM, CA, AR, KY, MD, WV and ME, addressing support, research or cultivation with bills or resolutions according to the HIA (Hemp Industries Association) website. 11 states have legalized industrial hemp production and at this rate I’m of the opinion that both marijuana and industrial hemp are federally legal inside of 10 years.

    Companies are looking to the future.

    With 25,000 products with hemp in them, companies like Stevia Corp (ticker STEV) and CannaVEST (ticker CANV) see the value in the half a billion dollar hemp industry in the United States. Stevia Corp recently founded Real Hemp, a subsidiary with the sole purpose of cultivating hemp. Said George Blankenbaker, “The growth in the hemp market is being fueled by the increased public knowledge of hemp and its many benefits and the market will continue to grow as more public awareness occurs. I am currently in Asia where more than 70% of the world hemp supply is grown, working with my team to confirm quality suppliers and products.” He added, “Even with all the known benefits of hemp, I believe the long-term hidden value is the cannabinoid content. Although hemp is bred to produce low levels of THC, it still produces all of the other known cannabinoids common to medical marijuana, many of which are being studied for their effectiveness against cancer and other diseases. I believe continuing to leverage our current experience and expertise gained working with stevia to identify and extract specific compounds will lead to substantial value working with hemp long-term.” Stevia Corp is on the verge of its first full harvest and will be launching its line of hemp products in the near future realhemp.com. Cannavest (CANV) on the flip side creates a unique product line using industrial hemp to make CBD oils etc (for more info http://cannavest.com/).

    industrialhemp

    So I guess the real question here is, how much longer can we ignore all of the benefits, uses, and economic value of industrial hemp?